NTLA fundamentals
An in-depth look to Intellia Therapeutics, Inc. operating, investing, and financing activities
NTLA free cash flow for Q4 23 is -94.57 M USD. For 2023, NTLA free cash flow was -408.07 M USD and operating cash flow was -394.09 M USD.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM